Avita Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $19M | 1.4M | 13.72 |
| 2023-09-30 | $20M | 1.4M | 14.61 |
| 2023-06-30 | $23M | 1.3M | 17.01 |
| 2023-03-31 | $17M | 1.2M | 13.97 |
| 2022-12-31 | $7.6M | 1.1M | 6.60 |
| 2022-06-30 | $5.5M | 1.1M | 4.75 |
| 2022-03-31 | $11M | 1.3M | 8.48 |
| 2021-09-30 | $22M | 1.3M | 17.72 |
| 2021-06-30 | $27M | 1.3M | 20.52 |
| 2021-03-31 | $21M | 1.1M | 19.91 |
| 2020-12-31 | $6.4M | 343k | 18.56 |
| 2020-09-30 | $7.2M | 285k | 25.16 |